On August 6, 2024, OneBlood posted a notice on its website discussing a ransomware attack. News of this cyberattack has…
Read More →
Recently, hackers claimed to have obtained a vast amount of personal information through a cyberattack targeting National Public Data d/b/a…
Read More →
I may be jumping the gun here, but I’m anxious to understand how the new flurry of AI medical devices…
Read More →
On July 30, 2024, Special Health Resources of Texas, Inc. (“SHRT”) filed a notice of data breach with the U.S.…
Read More →
In a closely watched case, the U.S. Consumer Product Safety Commission (CPSC) on July 29, 2024, found that Amazon’s popular…
Read More →
The U.S. Patent and Trademark Office (USPTO) has issued new guidance on patent subject matter eligibility, specifically concerning AI inventions.…
Read More →
Acuitas Therapeutics Inc. (“Acuitas”) filed a complaint (1-24-cv-00816) on July 12 against Alnylam Pharmaceutical Inc. (“Alnylam”) in the U.S. District…
Read More →
Maintaining compliance is your job. But sometimes that job feels like a slog through the deepest jungle. More than 130…
Read More →
Now nearly a year on from its 2023 Notice of Inquiry, the U.S. Copyright Office has now released Part 1…
Read More →
In our latest blog post on preparing for the EU’s Digital Operational Resilience Act (DORA), entering into force on January…
Read More →